Upon internalization by B-ALL cells, these EVs enhance the phosphorylation of protein kinase B (AKT) and focal adhesion kinase (FAK), thereby promoting BCR-ABL1+ B-ALL cell proliferation, migration, and progression. Here, PTK2 is linked to acute lymphoblastic leukemia.